recombinant

Recombinant antibodies offer precision and consistency. Biointron outlines how DNA technology produces synthetic antibodies for research and clinical applications.

Antibody production underpins biotech progress. Biointron explains traditional and recombinant methods that enable scalable, reliable antibody development.

This month heralded the release of groundbreaking news involving the monoclonal antibody tegoprubart, which facilitated the successful transplantation of a genetically edited pig kidney into a 62-year-old man grappling with end-stage kidney disease.

Single B cell technology accelerates antibody discovery. Biointron demonstrates how this approach delivers potent candidates faster and with greater precision.

Learn how recombinant antibody production uses genetic engineering to create highly specific antibodies, replacing traditional methods for therapeutic and diagnostic use.

Automation transforms antibody workflows. Discover robotic systems and integrated platforms that raise throughput, consistency, and data confidence.